Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Decitabine and Sorafenib Therapy in Patients with FLT3-ITD Mutant Acute Myeloid Leukemia Is Associated with High Response Rates—a Single Institute Experience

Monica Reddy Muppidi, MD, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Laurie A Ford, BS, CCRC, Craig W Freyer, Pharm.D., BCOP, Meir Wetzler, MD, Eunice S. Wang, MD

Blood (2014) 124 (21): 5284.

https://doi.org/10.1182/blood.V124.21.5284.5284

Published: 2014

Journal Articles

A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

Elizabeth A. Griffiths, MD, William Brady, Wei Tan, Carlos E Vigil, MD, James E. Thompson, MD, Laurie A Ford, BS, CCRC, Noelle M Dickey, BS, Jill Sperrazza, BS, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2014) 124 (21): 2318.

https://doi.org/10.1182/blood.V124.21.2318.2318

Published: 2014

Journal Articles

Presence of Isocitrate Dehydrogenase (IDH) Mutations May Predict Clinical Response to Hypomethylating Agents in Patients with Acute Myeloid Leukemia (AML)

Elizabeth A. Griffiths, MD, Brandon Carter-Cooper, BS, Seda Tolu, BS, Laurie A Ford, BS, CCRC, Rena G. Lapidus, PhD, Meir Wetzler, MD, Eunice S. Wang, MD, Arash Etemadi, MD PhD, Ashkan Emadi, MD, PhD

Blood (2014) 124 (21): 3724.

https://doi.org/10.1182/blood.V124.21.3724.3724

Published: 2014

Journal Articles

Comparison Of Epigenetic Versus Intensive Chemotherapy For Newly Diagnosed Acute Myeloid Leukemia Patients ≥60 Years Old: The Roswell Park Experience

Neha Gupta, MD, Shipra Gandhi, MD, Austin Miller, PhD, Laurie A Ford, BS, CCRC, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Meir Wetzler, MD, Eunice S. Wang, MD

Blood (2013) 122 (21): 1445.

https://doi.org/10.1182/blood.V122.21.1445.1445

Published: 2013

Journal Articles

Conventional Dose Hypomethylating Agents Induce CG Antigen Genes In Vivo

Elizabeth A Griffiths, MD, Adam R. Karpf, PhD, Kunle Odunsi, MD, PhD, Smitha R James, MS, Amy F Beck, Meir Wetzler, MD, Laurie A Ford, BS, CCRC

Blood (2011) 118 (21): 2441.

https://doi.org/10.1182/blood.V118.21.2441.2441

Published: 2011

Journal Articles

Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function

Michael T Brady, PhD, Austin Miller, PhD, Sheila Sait, PhD, Laurie A Ford, BS, CCRC, Minderman Hans, PhD, Eunice S. Wang, MD, Kelvin P Lee, MD, Heinz Baumann, Meir Wetzler, MD

Blood (2010) 116 (21): 3140.

https://doi.org/10.1182/blood.V116.21.3140.3140

Published: 2010

Journal Articles

Subnormal Vitamin D Levels Are Associated with Adverse Outcome In Newly-Diagnosed Similarly-Treated Adult Acute Myeloid Leukemia (AML) Patients.

Hun Ju Lee, MD, Josephia Muindi, MD, PhD, Tan Wei, MA, Gregory Wilding, Laurie A Ford, BS, CCRC, Sheila Sait, Annmarie Block, PhD, Maurice Barcos, MD, PhD, Carlos E. Vigil, MD, Elizabeth A Griffiths, MD, James E. Thompson, MD, Eunice S. Wang, MD, Candace S. Johnson, PhD, Donald Trump, MD, FACP, Meir Wetzler, MD, FACP

Blood (2010) 116 (21): 1041.

https://doi.org/10.1182/blood.V116.21.1041.1041

Published: 2010

Journal Articles

Amonafide L-Malate Bypasses Multidrug Resistance Proteins in Secondary Acute Myeloid Leukemia.

Kieran L. O’Loughlin, BS, Hans Minderman, PhD, Laurie A. Ford, BS, Maria R. Baer, MD

Blood (2007) 110 (11): 2380.

https://doi.org/10.1182/blood.V110.11.2380.2380

Published: 2007

Journal Articles

Long-Term Outcome of Cyclosporin A Therapy for T-Cell Large Granular Lymphocyte Leukemia.

Attaphol Pawarode, MD, Paul K. Wallace, PhD, Laurie A. Ford, BS, Maurice Barcos, MD, PhD, Maria R. Baer, MD

Blood (2007) 110 (11): 2063.

https://doi.org/10.1182/blood.V110.11.2063.2063

Published: 2007

Journal Articles

Randomized Trial of GM-CSF and G-CSF Following High-Dose Cytarabine and Mitoxantrone Chemotherapy for Relapsed and Refractory Acute Leukemia.

Maria R. Baer, MD, Laurie A. Ford, BS, Brian N. Bundy, PhD, Sheila M. Tighe, BS, Kieran L. O’Loughlin, MS, James L. Slack, MD, Meir Wetzler, MD, Paul K. Wallace, PhD

Blood (2006) 108 (11): 4574.

https://doi.org/10.1182/blood.V108.11.4574.4574

Published: 2006

Journal Articles

The mTOR Inhibitor Rapamycin Inhibits Drug Transport in Multidrug Resistant Cell Lines and in Acute Myeloid Leukemia (AML) Cells.

Attaphol Pawarode, MD, Kieran L. O’Loughlin, MS, Nicholas W. Cuviello, William R. Greco, PhD, Laurie A. Ford, BS, Hans Minderman, PhD, Maria R. Baer, MD

Blood (2005) 106 (11): 1512.

https://doi.org/10.1182/blood.V106.11.1512.1512

Published: 2005

NARROW

Decitabine and Sorafenib Therapy in Patients with FLT3-ITD Mutant Acute Myeloid Leukemia Is Associated with High Response Rates—a Single Institute Experience

A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

Presence of Isocitrate Dehydrogenase (IDH) Mutations May Predict Clinical Response to Hypomethylating Agents in Patients with Acute Myeloid Leukemia (AML)

Comparison Of Epigenetic Versus Intensive Chemotherapy For Newly Diagnosed Acute Myeloid Leukemia Patients ≥60 Years Old: The Roswell Park Experience

Conventional Dose Hypomethylating Agents Induce CG Antigen Genes In Vivo

Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function

Subnormal Vitamin D Levels Are Associated with Adverse Outcome In Newly-Diagnosed Similarly-Treated Adult Acute Myeloid Leukemia (AML) Patients.

Amonafide L-Malate Bypasses Multidrug Resistance Proteins in Secondary Acute Myeloid Leukemia.

Long-Term Outcome of Cyclosporin A Therapy for T-Cell Large Granular Lymphocyte Leukemia.

Randomized Trial of GM-CSF and G-CSF Following High-Dose Cytarabine and Mitoxantrone Chemotherapy for Relapsed and Refractory Acute Leukemia.

The mTOR Inhibitor Rapamycin Inhibits Drug Transport in Multidrug Resistant Cell Lines and in Acute Myeloid Leukemia (AML) Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only